{
  "main_header": {
    "sid": 783025,
    "name": "Amerise BioScie",
    "stock_name": "Amerise BioScie",
    "full_name": "Amerise Biosciences Ltd",
    "name_url": "stocks-analysis/amerise-bioscie",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.69",
    "chg": 0.03,
    "chgp": "4.55%",
    "dir": 1,
    "prev_price": "0.66",
    "mcapval": "4.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531681,
    "symbol": "",
    "ind_name": "Plastic Products - Industrial",
    "ind_code": 5,
    "indexname": "",
    "isin": "INE673C01020",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "4.84 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/amerise-bioscie-783025-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Amerise BioScie falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-amerise-bioscie-fallingrising-3681591",
        "imagepath": "",
        "date": "2025-11-08 00:04:01",
        "description": "As of 07-Nov, Amerise Biosciences Ltd is experiencing a decline in its stock price, currently at 0.61, which reflects a decrease of 0.04 or 6.15%. The stock has underperformed its sector by 7.67% today, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 29.59% compared to the 5-day average. Over the past year, the stock has seen a substantial decline of 44.55%, while its year-to-date performance shows a decrease of 49.59%. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.\n\nIn the broader market context, Amerise Biosciences Ltd's short-term performance over the past week shows a decline of 3.17%, while the benchmark Sensex has only decreased by 0.86%. This indicates that the stoc..."
      },
      {
        "title": "How has been the historical performance of Amerise BioScie?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-amerise-bioscie-3677353",
        "imagepath": "",
        "date": "2025-11-06 23:03:29",
        "description": "Answer:\nThe historical performance of Amerise BioScie shows a trend of minimal activity and fluctuating financial metrics over the years, with net sales consistently at zero from March 2020 to March 2025. Other operating income peaked at 9.01 crore in March 2022 but has since declined to 0.19 crore in March 2025. Total operating income followed a similar pattern, dropping from 9.01 crore in March 2022 to 0.19 crore in March 2025. The company reported total expenditure excluding depreciation of 0.18 crore in March 2025, which is significantly lower than the 9.03 crore recorded in March 2022. Operating profit (PBDIT) showed a recovery to 0.01 crore in March 2025 from a loss of 0.34 crore in March 2021, but overall profitability remains weak, with profit after tax at 0.01 crore in March 2025 compared to a profit of 0.55 crore in March 2022. The balance sheet reflects total liabilities of 8.46 crore in March 20..."
      }
    ],
    "total": 75,
    "sid": "783025",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/amerise-biosciences-783025"
  },
  "announcements": [
    {
      "caption": "Regulations 30 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "02-Feb-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "02-Feb-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 2Nd February 2026",
      "datetime": "02-Feb-2026",
      "details": "Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Monday 2nd February 2026 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and nine months ended as on 31st December 2025. 2.) Considered and approved the appointment of Mr. Albert Hines (DIN No.: 10742692) as Wholetime Director and Chief Financial Officer of the Company w.e.f 02.02.2026 3.) Considered and accepted the resignation of Mr. Dinesh Rathod DIN No.: 9406871) from the post of Wholetime director and Chief Financial Officer of the Company w.e.f 02.02.2026 The board meeting commenced at 03:45 PM and concluded at 04:15 PM Please take the above intimation in your records.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Amerise BioScie falling/rising?

2025-11-08 00:04:01

As of 07-Nov, Amerise Biosciences Ltd is experiencing a decline in its stock price, currently at 0.61, which reflects a decrease of 0.04 or 6.15%. The stock has underperformed its sector by 7.67% today, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 29.59% compared to the 5-day average. Over the past year, the stock has seen a substantial decline of 44.55%, while its year-to-date performance shows a decrease of 49.59%. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement. In the broader market context, Amerise Biosciences Ltd's short-term performance over the past week shows a decline of 3.17%, while the benchmark Sensex has only decreased by 0.86%. This indicates that the stoc...

Read More

How has been the historical performance of Amerise BioScie?

2025-11-06 23:03:29

Answer: The historical performance of Amerise BioScie shows a trend of minimal activity and fluctuating financial metrics over the years, with net sales consistently at zero from March 2020 to March 2025. Other operating income peaked at 9.01 crore in March 2022 but has since declined to 0.19 crore in March 2025. Total operating income followed a similar pattern, dropping from 9.01 crore in March 2022 to 0.19 crore in March 2025. The company reported total expenditure excluding depreciation of 0.18 crore in March 2025, which is significantly lower than the 9.03 crore recorded in March 2022. Operating profit (PBDIT) showed a recovery to 0.01 crore in March 2025 from a loss of 0.34 crore in March 2021, but overall profitability remains weak, with profit after tax at 0.01 crore in March 2025 compared to a profit of 0.55 crore in March 2022. The balance sheet reflects total liabilities of 8.46 crore in March 20...

Read More

View All News